---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-012650"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:53:09.362129+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio issues $6M Series A-1 Preferred to existing investor Patel; convertible into 600K common shares

## Summary
- Sold 600 shares Series A-1 Preferred Stock at $10,000/share for aggregate $6.0M to The Patel Family, LLP.
- Preferred carries 5% annual cumulative dividend increasing 2% yearly (capped at 15%); convertible into 600,000 common shares.
- Company has call right if 20-day VWAP > $5.00 and resale registration effective; non-voting, no mandatory redemption.
- Investment made under Section 4(a)(2) exemption; existing investor Dr. Manmohan Patel is beneficial owner >5%.
- Series A-1 ranks pari passu with Series A, senior to Common and Series B.

## SEC filing metadata
- accession: 0001493152-24-012650
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224012650/0001493152-24-012650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224012650/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-012650
- JSON: https://secwatch.observer/filing/0001493152-24-012650.json
- Plain text: https://secwatch.observer/filing/0001493152-24-012650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.